The 2026 European MedTech and HealthTech Valuation Landscape: A Strategic Assessment of Industrial Maturity and Regulatory DarwinismThe European healthcare technology and medical technology sectors have transitioned into a definitive era of disciplined industrial maturity as of February 2026. This phase, widely characterised by market analysts as the Great Rationalisation, marks the final pivot away from […]
